TL1A Therapeutics in IBD [#0005] Session Title: IBD: Omics for Diagnosis, Disease Stratification and Therapy Selection Title: Omilancor Reverses Colonic Treg Depletion and Downregulation of ...

Over roughly 9 years of follow-up, people with the swallowing disorder achalasia had a 42% higher risk of mortality compared ...

Patients with LVV and IBD present with distinct clinical characteristics, including earlier onset and more severe vascular involvement.

Using vedolizumab first, before tumor necrosis factor-α inhibitors, improved quality-adjusted life-years in both ulcerative ...

The long-term incidence of MACE, VTE, and malignancies is low among patients with RA or UC receiving filgotinib, though a slight increase was observed among older patients.

Inflammatory bowel disease (IBD) is associated with increased risks for genitourinary cancers, including prostate cancer and renal cell carcinoma (RCC), according to study results presented at the ...

The FDA has approved Tremfya (guselkumab) for the treatment of adults with moderately to severely active Crohn disease.

Pannexin 1 (PANX1) forms channels that may release signaling metabolites that are involved in a variety of pathophysiological processes, such as asthma, diabetes, hypertension or inflammatory bowel ...

A study published today in the American Journal of Gastroenterology reveals significant disparities in healthcare utilization ...

A study published in the American Journal of Gastroenterology reveals significant disparities in health care utilization ...

Ella Rhian had never experienced any stomach problems before and lived a normal, healthy life. Then, in September 2023, the ...

So when Ricario was diagnosed with ulcerative colitis (UC) at the age of 40 ... During long-haul flights people with ...